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Abstract 
 
Background: Skin and soft tissue infections (SSTI) have risen sharply over the last decade as a 
result of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). 
Evaluations of national databases have shown an increase in healthcare visits due to CA-MRSA, 
but do not include federal healthcare facilities, including the military.  This study evaluates the 
trends in SSTI likely related to CA-MRSA across the Department of Defense from 1999-2008. 
Methods:  A dataset was constructed using the Defense Medical Epidemiology Database using 
ICD-9 codes for carbuncle/furuncle during the time of interest.  Data was then stratified to 
specific service components, Army personnel category, and Army military occupational 
specialty category.  Results:  There was a 6.3 fold increase in SSTI from 1999-2003.  The largest 
proportion of infections occurred in the Army.  Of the 10,950 infections in the Army in 2008, 
94% occurred in enlisted personnel.  Military occupational specialties with the highest rates of 
infection included crafts workers and electronic / mechanical repairers. Limitations:  This study 
is limited due to use of secondary data and lack of culture data to clearly determine the presence 
of CA-MRSA.  Conclusions:  SSTI in the Department of Defense has increased in a similar 
fashion to national civilian reports.  Further evaluation of populations with highest rates of 
infection is warranted to assist with determination of risk factors and effective eradication 
strategies. 
 
 
 
 
 
 
 
 
 
Background: 
Skin and soft tissue infections (SSTI) traditionally have accounted for 1-2% of all 
emergency department visits, but the incidence of SSTI’s has risen sharply over the last decade.1  
An evaluation of the National Ambulatory Medical Care Survey and the National Hospital 
Ambulatory Medical Care Survey shows visits for SSTI increased by 59% in outpatient clinics 
and 31% in emergency departments from 1992-2003.2   
The typical causative agents of SSTI included Streptococcus species and Staphylococcus 
aureus.  While traditionally susceptible to most antibiotics, including penicillin, the increased 
incidence of SSTI has been correlated with an increased incidence of methicillin-resistant 
Staphylococcus aureus (MRSA).  MRSA was first discovered in 1960 and was found to be a 
nosocomial pathogen.3  Patients at risk for hospital acquired MRSA (HA-MRSA) included those 
with previous antibiotic use, contact with a healthcare worker or nursing home resident, 
residence in a long-term care facility, hospitalization, admission to an intensive care unit, 
hemodialysis or peritoneal dialysis, mechanical ventilation, tracheostomy tube, nasogastric tube, 
gastrostomy tube, or Foley catheter, total parenteral nutrition or enteral feeding, surgical 
procedures, and previous isolation of MRSA.3,4  More recently MRSA has been implicated in 
SSTI in outpatients without any risk factors for HA-MRSA.  These infections have been deemed 
community acquired MRSA infections (CA-MRSA).   
Distinct microbiologic and biochemical differences separate HA-MRSA and CA-MRSA.  
Methicillin resistance is a result of a change in the penicillin-binding protein 2a which is encoded 
on the mecA gene of the Staphylococcal cassette chromosome (SCC).  Five SCC types have been 
identified and types I, II, and III are associated with HA-MRSA and type IV is associated with 
CA-MRSA.  In addition to the change in the penicillin-binding protein, CA-MRSA isolates are 
more likely to produce exotoxins, such as the Panton-Valentine leukocidin (PVL) toxin which is 
a dermonecrotic toxin allowing for more aggressive skin penetration and abscess development.4  
Pulsed Field Gel Electrophoresis evaluation can be used to differentiate between genetic clones.  
Common clones include USA 400 and USA 300.  USA 400 is highly virulent and contains 16 
unique superantigen genes in addition to PVL, but is a less frequent source of infection.5 USA 
300 is much more common and reached epidemic and then endemic proportions in the U.S.6  
Molecular typing has shown that in some institutions the USA 300 clone caused greater than 
80% of CA-MRSA infections in the US mainland7, while the epidemiology of CA-MRSA in 
Alaska has not shown such USA 300 predominance.8  
SSTI resulting from CA-MRSA often present as a tender erythematous abscess, cellulitis, 
or both and is often initially thought to be secondary to an insect or spider bite.4 Approximately 
50-75% of patients present with an abscess and 25-50% present with cellulitis.16  Outbreaks of 
CA-MRSA have been noted in contact sports teams, such as football9, fencing, and wrestling.10,11 
A comprehensive review of cutaneous manifestations of CA-MRSA by Cohen notes reports of 
cases occurring in professional, college and high school football players; rugby players, baseball 
players, basketball players, canoers, fencers, soccer players, volleyball players, and weight 
lifters.12 Risk factors identified for CA-MRSA include jail detainees, military recruits, children 
attending day care centers, participants in contact sports, urban dwellers of low socioeconomic 
status living in crowded conditions, tattoo recipients, homeless youth, men who have sex with 
men, HIV-infected individuals, African Americans, Pacific Islanders, and Native Americans.13 
Moreover, public housing was found to be a core group with increased odds of CA-MRSA 
infection14 as well as use of methamphetamine.15  
Evaluation of national surveys has shown increased diagnosis of SSTI in several different 
clinical settings.  Pallin, et al, analyzed data from the National Hospital Ambulatory Medical 
Care Survey (NHAMCS) from 1993-2005 and found that the number of emergency department 
visits increased markedly from 1.2 million visits to 3.4 million visits.17 Hersh, et al, used data 
from the National Ambulatory Medical Care Survey (NAMCS) and the NHAMCS to estimate 
the annual visit rates for all SSTI and a subset classified as abscess/cellulitis. They report that the 
rates of visits for SSTI increased from 32.1 to 48.1 visits per 1000 population from 1997 to 2005 
reaching 14.2 million visits with greater than 95% of change resulting from abscess/cellulitis.18  
The largest relative increase occurred in the emergency department.  Pallin further assessed the 
NAMCS from 1993 to 2005 and found that the rate of diagnosis of SSTI did not increase in 
physician office visits and corroborated the results from Hersch that the increased burden of 
SSTI from CA-MRSA was most commonly seen in the emergency department.19 Each of these 
studies relied on data from the NAMCS and the NHAMCS to determine estimates of SSTI 
incidence.  The NAMCS data is collected from a sample of visits to non-federal employed 
office-based physicians who are primarily engaged in direct patient care.  The NHAMCS data is 
based on a national sample of visits to the emergency departments and outpatient departments of 
non-institutional general and short-stay hospitals. Neither of these databases includes data from 
federal facilities, to include prisons and military treatment facilities.  This project was completed 
to evaluate the trends of SSTI in the Department of Defense during a 10 year period from 1999-
2008.   
 
 
 
Methods: 
A descriptive study of nested data in the Defense Medical Epidemiology Database 
(DMED) was undertaken to determine trends in SSTI in the Department of Defense from 1999 
thru 2008.  Goals of this project are to determine changes in the occurrence of SSTI in the 
Department of Defense and to evaluate differences between service components (Army, Navy, 
Air Force, and Marines).  Secondary aims of this study are to evaluate differences between 
personnel status (officers and enlisted), differences between military occupational specialty 
categories, and differences in body location of SSTI in the Army sub-group as the prevalence of 
CA-MRSA has increased in the general population.  This project was approved as an exempt 
protocol by the University of North Carolina-Chapel Hill Institutional Review Board.  
DMED provides on-line access to subsets of data in the Defense Medical Surveillance 
System (DMSS), to include hospitalizations and ambulatory visits for all active duty and reserve 
components. Information collected in DMSS is acquired from over 100 different field sites and 
contains longitudinal records for all individuals who have served in the armed forces since 1990.  
DMED allows users to access a searchable database consisting of 4 types of data relevant to 
active duty service members: demographic data, inpatient hospitalization data, ambulatory data, 
and reportable events data.  Ambulatory data is generated by military treatment facilities and out-
sourced out-patient healthcare non-DoD clinics using standard diagnostic codes.  Personnel 
demographic information allows evaluation of overall and stratum-specific population statistics 
(i.e.person-year denominators) based on longitudinal personnel data.  DMED queries provide the 
count of cases, the cumulative person years of experience during the calendar years of interest, 
and the rates of occurrence of cases for the selected population substrata.20 
Queries for this project were made using the International Classification of Disease, 
Ninth Revision Clinical Modification (ICD-9-CM) 3 digit code (680) for carbuncle/furuncle as 
the primary diagnosis in the ambulatory data set for years 1999-2008.  While previous studies 
have used several subsets of SSTI, carbuncle/furuncle was used for this project as it has been 
noted in previous studies to correlate to infections with CA-MRSA.21  The ten year period from 
1999-2008 was selected to capture time before and after the inflection point for increased CA-
MRSA infections in the civilian population that occurred around 2000-2003.22 Information was 
set to include all genders, all ages, all races, all marital statuses, all occupations, and all 
locations.  The data set was then filtered to develop an Army specific dataset that was divided 
into personnel category (enlisted personnel vs officers).  Each category was then filtered to sub-
sets based on military occupational specialty categories.  Enlisted categories consisted of the 
following:  
1) Infantry, Gun Crews, and Seamanship Special     
2) Electronic Equipment Repairers    
3) Communications and Intelligence Specialist 
4) Healthcare Specialists 
6) Functional Support and Administration  
7) Electrical/Mechanical Equipment Repairers  
8) Crafts workers 
Lastly, the Army dataset was filtered by ICD-9-CM to specific body location using the following 
codes: 
 1) 680.0 - Face 
2) 680.1- Neck 
3) 680.2 -Trunk 
4) 680.3 – Upper arm and forearm 
5) 680.4 - Hand 
6) 680.5 - Buttock 
7) 680.6 – Leg except foot 
8) 680.7 – Foot 
9) 680.8 - Other specified site 
10) 680.9 - Unspecified site 
Each data set was then imported into an Excel spreadsheet for development of graphs and bar 
charts.  Trend analysis was then performed with least squares linear regression using Graphpad 
Prism 5 to compare the slope selected sub-set data.    
 
Results: 
Service Component 
Raw counts for each service component by year increased substantially from 1999 thru 
2008 (Table 1).  There were a total of 60,144 cases of carbuncle/furuncle in the Department of 
Defense during this time frame.  Most of the infections were in the Army with a total of 28,934 
(48%).  Similar numbers occurred in the Navy and Air Force, 12,466 (21%) and 12,974 (21%), 
respectively. The smallest number occurred in the Marines with 5,770 infections (10%).  In 
1999, there were a total of 1,735 infections, with a similar proportion occurring in the Army 
(27.2%), Navy (28.4%), and Air Force (31.2%) and a smaller proportion in the Marines (13.2%).  
There was a 6.3 fold increase in infections from 1999 to 2008.  There were 10,950 infections in 
2008 with 52.3% occurring in the Army.  The Navy, Air Force, and Marines had lower 
proportions of 18.7%, 19.6%, and 9.5% respectively. During this ten year period, infections in 
the Army had a 12-fold increase from 472 to 5,723.  Increased counts also occurred in the Navy 
(4-fold), Air Force (4-fold), and Marines (4.5-fold) during this time, however, at lower amounts.  
Rates per 1,000 persons per year were similar for each branch of service in 1999, ranging from 
1.01 in the Army to 1.34 in the Marines.  In 2008, there were substantial differences between the 
rate in the Army and the other services with 10.79 infections per 1,000 persons in the Army and 
a range of 5.34 to 6.61 per 1,000 in the Navy, Air Force, and Marines.  The lowest rate occurred 
in the Army in 1999 and the highest rate was in the Army in 2007 at 11.25 per 1,000 per year 
(Figure 1).  Trend analysis revealed a significant difference between rates in the Army compared 
to rates in all other service components (p <0.0001).     
Army Personnel Category 
Raw data for the Army filtered by personnel category is included in Table 2 and graphed 
in Figure 2.  Ninety-three percent of infections occurred in enlisted personnel.  In 1999, 88% of 
infections occurred in enlisted members and in 2008 they accounted for 94%.  Enlisted rates per 
1,000 persons went from 1.05 to 11.99 during the study period and the rates for officers 
increased from 0.72 to 4.06.  The lowest rate occurred in officers in 1999 and the highest rate 
occurred in enlisted members in 2007.  Changes in rates per 1,000 persons per year for the Army 
revealed a significant difference in the incidence of SSTI between officer and enlisted categories 
(p<0.01) (Figure 3).  
Army Military Occupational Specialty Category 
Enlisted military occupational specialty categories in DMED include infantry, craft 
workers, electronic repair, healthcare, communications/intelligence, electrical/mechanical repair, 
and functional support/administration.  Raw counts by category are presented in Table 3 and 
rates are shown in Figure 4.  In 1999, the majority of infections occurred in the infantry (27.4%) 
and functional support and administration (25.6%).  From 1999 to 2008, there was a 12.5-fold 
increase in infections among enlisted personnel.  The percent occurring in the infantry decreased 
to 23.3% and functional support and administration decreased to 21.4%, while all other 
categories increased in percentage of infection with the exception of healthcare workers.  In 
1999, rates per 1,000 persons ranged from 0.74 in electronic repair to 1.25 in healthcare.  In 
2008, rates varied from 8.56 per 1,000 in the infantry to 15.65 per 1,000 in craft workers.  The 
lowest rate occurred in electronic repair in 1999 (0.74 per 1,000) and the highest rate occurred in 
electrical/mechanical repair in 2007 (17.1 per 1,000).  There was a significant difference between 
groups (p = 0.007) with the largest increase in rates occurring with electronic/mechanical repair 
and craft workers.  The lowest increases in rates per 1,000 persons occurred in the infantry and 
communications/intelligence.   
Body Location 
A graph of raw counts by body location for the Army is shown in Figure 5.  In 1999, the 
majority of infections occurred on the leg (26.8%) and face (20.7%).  In 2008, the majority of 
infections occurred on the arms (21.4%), legs (20.3%), trunk (18%) and buttocks (15.1%).  The 
greatest percentage increase during the study time occurred in the arm, trunk, and buttock.   
Significant differences existed between body location over the study period (p<0.001).  The 
highest rate of increase occurred in the arm, leg, trunk and buttocks.  A chart comparing 
distribution of SSTI in 1999 and 2008 is shown in Figure 6. 
Discussion: 
The incidence of MRSA has risen sharply and it is now the most common cause of SSTI 
with 97% being community acquired.23  This is a significant change from reports in the 1990’s 
when no isolates of MRSA was isolated from SSTI and the most common etiology was 
methicillin-sensitive Staphylococcus aureus.24  There was an increase in overall diagnosis of 
carbuncle/furuncle across the DoD from 1999-2008 with an inflection point occurring near 2003.  
The rates of infection in the DoD were comparable to that of cited civilian rates ranging from 
17.3 to 32.5 visits per 1,000 population for the diagnosis of abscess/cellulitis.18  
Within DoD, there was a substantially higher number infections and a higher rate of 
infection in the Army.  This may be related to the type of training and living conditions 
experienced by those in the Army, compared to the other components.  Surprisingly, there was a 
significant difference between the Army and Marines which, intuitively, would be similar given 
the similar exposure to living in field conditions and training.   
A distinct difference in number of infections and rates exists between enlisted members 
and officers in the Army.  This may be a reflection of environmental exposures and living 
conditions.  Military members have traditionally been cited as a group with increased risk for 
MRSA due to the potential for close contact, sharing of personal equipment, and situations that 
lack ability to maintain personal hygiene.  This is more likely to occur among enlisted members 
as they are more likely to live in barracks or shared housing.  Sharing of personal hygiene items 
and close physical association with those with SSTI has been shown to be risks for both infection 
and nasal carriage of CA-MRSA on sports teams.
25
  Sharing of personal hygiene items may 
occur more often in the close proximity of barracks living.  Similar findings in sports personnel 
have shown that sharing hygiene items or having items in proximity may lead to increased 
infections and colonization.  An evaluation of recurring MRSA infections in a football team 
revealed that sharing bars of soap and having pre-existing cuts or abrasions were risk factors for 
infection and having a locker near a teammate with an SSTI and sharing towels were associated 
with nasal carriage.25    
The higher number of enlisted Army members with carbuncle/furuncles may be related to 
local outbreaks of CA-MRSA that occur within units or barracks.  Outbreaks of CA-MRSA in 
military personnel in these living conditions have been reported.26  The greatest risk factor during 
an outbreak among military trainees in San Diego, CA included having a roommate with a prior 
skin infection (odds ratio 3.44).27  Given the number of infections in the Army and access to 
several free healthcare venues (unit medic, battalion aid stations, troop medical clinics, and the 
emergency department), it is possible for small outbreaks to occur without recognition by public 
health authorities.    
Among enlisted members, the highest rates of infection occurred in craft workers and 
electrical/mechanical repair personnel.  While environmental exposure to field conditions among 
combat arms personnel would be expected to result in increased infections, this finding may 
relate to the role of fomites in development of infections.  Nasal colonization is an important 
aspect of the epidemiology of Methicillin-susceptible Staphylococcus aureus infection, but may 
not be as important in the transmission of CA-MRSA.28  Sharing of tools among craft workers 
and repair personnel could be responsible for the increased rate of infection among these 
soldiers.  Moreover, they may be more likely to develop skin abrasions or minor lacerations that 
could serve as a portal for infection.         
Over the 10 year period, there has been a substantial change in the body site location of 
SSTI with a substantially higher percentage of infections occurring in the arm, leg, trunk, and 
buttock and a decrease in infections on the face and neck.  The data from this study shows a 
similar prevalence to the anatomic distribution noted in a previous CA-MRSA outbreak in 
military recruits.26  The change in body site location may be related to environmental exposure to 
fomites and a change in body site location colonization.  Nasal colonization has been implicated 
as an important factor for methicillin susceptible S. aureus, and HA-MRSA, while colonization 
at non-nasal sites has been implicated for transmission and development of infection in patients 
with CA-MRSA.29  Colonization is likely to play a lessor role in the development of CA-MRSA 
SSTI dissemination as the percent of healthy populations with nasal colonization is 
approximately 1%.30 While, Zafar, et al, found that household contacts of patients with CA-
MRSA SSTI had higher nasal carriage rates than that of the general population, only half of 
household members carried the same strain as the patient, making direct transmission less 
likely.31   Ellis, et al, studied the natural history of CA-MRSA colonization and infection in a 
cohort of soldiers undergoing advanced individual training over a 10 week period.  Of 812 
soldiers that participated in the study, 24 were colonized with MRSA and 214 were colonized 
with methicillin-susceptible S. aureus.  At the end of the 10 week period, only 8 of the CA-
MRSA colonized soldiers remained colonized.  None of the methicillin-susceptible S. aureus 
carriers became colonized with MRSA.  Of the 523 that were not colonized at all on initial 
screening, only 4 developed MRSA colonization in the 10 week period while 40 became 
colonized with methicillin-susceptible S. aureus.  Of the initial 24 MRSA carriers, 9 developed 
soft tissue infections compared to 8 soft tissue infections in the group that was colonized with 
methicillin-susceptible S. aureus.  This study revealed that carriage of MRSA is associated with 
a higher attack rate of SSTI compared to carriage of methicillin-susceptible S. aureus.32  
However, additional sites of colonization, such as the groin and axilla, were not evaluated.      
Implications for interventions.  Identification of personnel with higher rates of infection may 
lead to efforts for eradication of colonization and enforcement of practices to decrease 
environmental contact.  Such procedures have been used in outbreaks of CA-MRSA among 
sports participants.  Recommendations for preventing staphylococcal skin infections among 
sports participants includes: 1) cover all wounds, 2) encourage good hygiene, including 
showering and washing with soap after all practices and competitions, 3) ensure availability of 
adequate soap and water, 4) discourage sharing of towels and personal items, 5) establish routine 
cleaning schedules for shared equipment, 6) train athletes and coaches in recognition of wounds 
that are potentially infected, 7) encourage athletes to report skin lesions.11 Use of contact 
precautions for persons with SSTI is supported by the changing epidemiology of these infections 
and is recommended by the Centers for Disease Control and Prevention.33  This would include 
identifying potential fomites and developing appropriate handling and cleaning procedures. 
Determining an intervention strategy to prevent the spread of CA-MRSA is also likely to have 
significant financial implications as infections with MRSA requiring hospitalization have been 
shown to be 2 -3 times as costly as those with MSSA infections.34  In outpatients, CA-MRSA is 
likely to require treatment with additional courses of antibiotics which also lead to increased 
economic impact.35  As increase in CA-MRSA SSTI has increased and treatment with B-lactam 
antibiotics has also decreased, a large percentage of patients are still treated with inactive 
antimicrobial therapy.36 This may lead to increased morbidity and expense for repeat treatment.  
Prevention of recurrence is also an issue.  Study of CA-MRSA SSTI in an urban jail showed a 6 
month recurrence rate of 14% compared to a recurrence rate of 8.8% for patients with MSSA 
SSTI.37  Decolonization for patients with recurrent infections may be of some benefit.  A 
prospective randomized placebo controlled study evaluating the use of whole-body washing with 
Chlorhexidine showed a significant decrease in groin-area colonization, but not for colonization 
of the nose, throat, and perineum.38 An expert panel in collaboration with the CDC has suggested 
that decolonization may be reasonable in 2 clinical situations: 1) for patients with multiple 
documented recurrences of MRSA infections and 2) for ongoing MRSA transmission in a 
closely associated and well-defined cohort of individuals (e.g. household). Outbreaks in military 
personnel may be candidates for decolonization therapy given their close association, specifically 
for those who live in close quarters, such as in the barracks.        
Limitations: 
This study is limited by the use of secondary data derived from a larger database of 
reported infections across the DoD.  While reporting of diagnosis and diagnostic codes are 
required for each visit, it is possible for diagnoses to be coded in error.  In some instances it is 
possible that no diagnostic code is reported, especially for personnel with unit level medics or aid 
stations that may treat soldiers without formal reporting.  This may be more likely to occur in 
combat arms units and could explain why they have a lower rate of infection in the database.   
Although this project shows that the incidence of SSTI has increased over the 10 year 
period, the exact incidence of CA-MRSA cannot be determined as culture information was not 
available in the database.  To minimize this issue only infection that would have a high 
correlation with CA-MRSA in previous studies were included in this evaluation by limiting the 
study to a diagnosis of carbuncle/furuncle.  While this makes the study more specific to CA-
MRSA, it has the potential to underestimate overall SSTIs.   
The inflection point for infections occurred around 2003 which is similar to reports in the 
civilian literature; however, deployment of a large number of personnel to field conditions in 
Iraq may have had an effect on the incidence of infection.  This may explain why the Army had a 
higher rate of SSTI than the other services, as they provide a larger quantity of soldiers to the 
battlefield.  A higher incidence rate for SSTI has been reported in a small study based at a single 
operating base in Baghdad, with an overall calculated incidence rate of 880 per 100,000 persons 
per year for all SSTI and 600 per 100,000 per year for CA-MRSA infections.39   
Future Research:  
Additional studies to further determine target populations for intervention and risk factors for 
SSTIs in soldiers are needed.  This would include focused questionnaires and environmental 
sampling in the personnel groups with the highest incidence of infection in this study.  Use of 
cultures will be imperative as it has been shown through a prospective study assessing risk 
factors that clinical and epidemiological risk factors are not able to distinguish between MRSA 
and MSSA infections.40  Further evaluation of colonization and its effect on development of 
infection and transmission is needed, specifically evaluating sites other than nasal colonization to 
include the groin and axilla.  A cohort study of soldiers to compare the impact of deployment on 
infection rates would also provide key information.   
Conclusion: 
Skin and soft tissue infections have risen dramatically across the United States, including the 
Department of Defense.  Previous studies have evaluated the impact of CA-MRSA on the 
increased incidence in the general population, but not the military.  This study shows that the rate 
of infection in the military has risen in a similar fashion.  Additionally, trends in the military 
have shown higher rates of infection in the Army, specifically among enlisted personnel.  
Military occupational specialty groups with the highest increase in rates include craft workers 
and repair personnel.  This may be related to occupational exposure to CA-MRSA through 
fomites.  Further studies to determine risk factors and environmental exposures are needed.   
  
Table 1.  Counts for SSTI in each service component from 1999-2008. 
 
 
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Army 472 1044 1236 1614 1664 2666 4174 4598 5743 5723 
Navy 493 663 646 895 1006 1245 1472 1936 2061 2049 
Air Force 541 813 1006 839 959 1352 1534 1627 2161 2142 
Marines 229 259 305 369 429 613 737 851 942 1036 
 
 
 Figure 1.  Rates per 1,000 persons per year of SSTI by service component from 1999-2008. 
 
  
 
 
 
 
 
 
 
 
Table 2.  Counts of SSTI for the Army by personnel category from 1999-2008. 
 
 
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Enlisted 412 940 1121 1481 1529 2472 3849 4219 5268 5317 
Officer 56 94 109 120 113 173 292 260 405 353 
 
Figure 2. Counts of SSTI for the Army by personnel category from 1999-2008. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Rates per 1,000 persons per year of SSTI by Army personnel category from 1999-2008. 
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Table 3. Counts of SSTI for enlisted soldiers by military occupational specialty category from 1999-2008. 
 
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Infantry 91 160 191 256 253 444 658 678 915 967 
Craftworkers 12 34 19 27 17 37 110 113 154 166 
Electronic Repair 26 50 63 120 160 190 335 267 344 275 
Healthcare 39 99 99 123 137 196 284 407 376 467 
Communications/Intelligence 32 77 118 123 166 221 306 368 595 523 
Electrical/Mechanical Repair 47 119 186 238 235 472 795 936 1011 862 
Functional Support and Administration 85 199 243 295 302 481 672 648 819 888 
 
 
Figure 4. Rates per 1,000 persons per year of SSTI by military occupational specialty category from 1999-2008. 
 
  
  
 
 
 
 
 
Figure 5. Counts of SSTI for the Army by body location from 1999-2008. 
 
 
 
 
Figure 6. Distribution of SSTI for the Army by body location from 1999-2008. 
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